compounded semaglutide risks semaglutide: Is it safe? The FDA's Decision to Ban

Retatrutides appetite effect does something that pure willpower almost never manages

This superior efficacy helped it achieve global sales of ~US$16.4bn in 2024 (Mounjaro ~US$11.5bn and Zepbound ~US$4.9bn), rivalling semaglutide and completely overshadowing the sales of historical GLP-1s, such as exenatide, liraglutide and dulaglutide [FIGURE TWO]

[11] [12] Hypoglycaemia : Particularly relevant if retatrutide is used alongside insulin or sulphonylureas

E.PierceR

Here are our top recommendations for managing hunger naturally when coming off of Mounjaro

The MHRA has disrupted two UK manufacturing facilities producing counterfeit retatrutide and tirzepatide pens, in October 2025 and February 2026